Wegovy, Saxenda Assist People Lose Kilos They Regained After Weight-Loss Surgical procedure


By Cara Murez HealthDay Reporter

(HealthDay)

Each work by controlling urge for food and satiety. Wegovy (semaglutide), nonetheless, could also be superior to Saxenda (liraglutide), a brand new examine finds.

“Our examine additionally discovered that weight administration remedy regimens containing semaglutide labored higher than these containing liraglutide, even when the dose of semaglutide was decrease than what’s at present authorised to deal with weight problems,” Almandoz stated in a college information launch.

Greater than 40% of American adults are overweight, in keeping with the U.S. Facilities for Illness Management and Prevention. Weight acquire after bariatric surgical procedure is frequent and may make kind 2 diabetes and fatty liver illness worse.

To see if remedy may assist this group of post-surgery sufferers, the brand new examine in contrast glucagon-like peptide-1 (GLP-1) receptor agonists Wegovy, which is given as a weekly injection, and Saxenda, a day by day injection.

The researchers analyzed well being information for 207 adults who beforehand had bariatric surgical procedure and had been then handled for weight problems at UTSW’s Weight Wellness Program between 2015 and 2021. The sufferers had been largely ladies, common age 55.

Sufferers had regained greater than 40% of the burden they misplaced after surgical procedure and had been a mean of eight years out from surgical procedure.

Every was assigned to take Wegovy or Saxenda for a minimum of three months. A yr later, these on Wegovy had misplaced about 13% of their physique weight on common. These taking liraglutide had misplaced about 9% on common.

Additionally, these within the Wegovy group had been greater than twice as prone to have misplaced a minimum of 10% of their physique weight, the examine discovered.

“Our outcomes assist the real-world effectiveness of GLP-1 receptor agonists for treating post-bariatric weight recurrence and recommend that semaglutide is superior to liraglutide,” Almandoz stated.

The examine was revealed on-line just lately within the journal Weight problems.

The U.S. Facilities for Illness Management and Prevention has extra on weight problems.

SOURCE: UT Southwestern, information launch, June 1, 2023

Copyright © 2023 HealthDay. All rights reserved.



Supply hyperlink

We will be happy to hear your thoughts

Leave a reply

Fitness Products
Logo
Enable registration in settings - general
Compare items
  • Total (0)
Compare
0
Shopping cart